AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33450486 — intervention group
Group type: COMPARATOR
Intervention: Continuous high-dose esomeprazole
Number of subjects: 414
Study 33882292 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited discharge (postoperative hospitalization duration of 0 or 1 day)
Number of subjects: 84152
Study 33882292 — intervention group
Group type: COMPARATOR
Intervention: Routine discharge (postoperative hospitalization longer than 1 day)
Number of subjects: 84152
Study 34377044 — intervention group
Group type: EXPERIMENTAL
Intervention: TDT 064 (topical agent)
Number of subjects: 64
Study 34377044 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical in appearance)
Number of subjects: 64
Study 32674230 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Protein Enteral Nutrition (TPEN)
Number of subjects: 120
Study 32674230 — intervention group
Group type: COMPARATOR
Intervention: Short Peptide Enteral Nutrition (SPEN)
Number of subjects: 120
Study 34321051 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term mentalisation-based therapy (20 weeks)
Number of subjects: 0
Study 34321051 — intervention group
Group type: COMPARATOR
Intervention: Long-term mentalisation-based therapy (14 months)
Number of subjects: 0
Study 36110081 — intervention group
Group type: EXPERIMENTAL
Intervention: Caries group (patients with caries)
Number of subjects: 43
Study 32847643 — intervention group
Group type: EXPERIMENTAL
Intervention: PRIDE intervention (three-session intervention)
Number of subjects: 34
Study 32847643 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative feedback from dyads and facilitators
Number of subjects: 34
Study 32325162 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Comprehensive Rehabilitation Program (ICRP) for 8 weeks
Number of subjects: 38
Study 32325162 — intervention group
Group type: COMPARATOR
Intervention: Leaflet with ergonomic information (Control)
Number of subjects: 38
Study 35842329 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate
Number of subjects: 150
Study 35842329 — intervention group
Group type: COMPARATOR
Intervention: Combined plating
Number of subjects: 150
Study 32495059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal anti-VEGF injection (bevacizumab or ranibizumab)
Number of subjects: 550
Study 32495059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal anti-VEGF injection (bevacizumab) in HTG
Number of subjects: 550
Study 32495059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal anti-VEGF injection (ranibizumab) in NTG
Number of subjects: 550
Study 36362815 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of colon-targeted microencapsulated sodium butyrate combined with probiotic Lactobacillus strains (L. rhamnosus and L. acidophilus) and Bifidobacterium strains (B. longum, B. bifidum, B. lactis), and 64 mg of prebiotic scFOS
Number of subjects: 120
Study 36362815 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 120
Study 36362815 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 120
Study 36362815 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 34810350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine mouth rinse
Number of subjects: 50
Study 34810350 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% green tea extract mouth rinse
Number of subjects: 50
Study 34244224 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine Diet (RD)
Number of subjects: 214
Study 34244224 — intervention group
Group type: COMPARATOR
Intervention: Low-Carbohydrate, High-Fat Diet (LCHFD)
Number of subjects: 214
Study 32127584 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use MR contrast injector (SI)
Number of subjects: 365
Study 32127584 — intervention group
Group type: COMPARATOR
Intervention: Multi-use MR contrast injector (MI)
Number of subjects: 365
Study 34809581 — intervention group
Group type: EXPERIMENTAL
Intervention: VieScope
Number of subjects: 35
Study 34809581 — intervention group
Group type: COMPARATOR
Intervention: GlideScope (Control)
Number of subjects: 35
Study 33085237 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP with a periodontal endoscope
Number of subjects: 0
Study 33085237 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 0
Study 34466041 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive deviance approach (PDA) intervention with counseling and social support to promote EBF
Number of subjects: 260
Study 34466041 — intervention group
Group type: COMPARATOR
Intervention: Usual community-based services from urban health extension professionals (Control)
Number of subjects: 260
Study 34466041 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive deviance approach (PDA) intervention
Number of subjects: 260
Study 33040012 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-RESPECT intervention involving comprehensive geriatric assessment, individualised care plan, medication and rehabilitation management, periodic video-conference, and in-system assessment.
Number of subjects: 0
Study 33040012 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0
Study 36216679 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 vaccine (two doses)
Number of subjects: 0
Study 36216679 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 booster dose
Number of subjects: 0
Study 36216679 — intervention group
Group type: COMPARATOR
Intervention: Adolescents (after school reopening)
Number of subjects: 0
Study 33940582 — intervention group
Group type: EXPERIMENTAL
Intervention: Swedish version of the ENDOCARE questionnaire (ECQ)
Number of subjects: 187
Study 32910638 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis of papillae geometry and adhesive performance using an image processing tool.
Number of subjects: 0
Study 32910638 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical modeling of surface structures.
Number of subjects: 0
Study 32910638 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigation of surface area changes of papillae with fish size.
Number of subjects: 0
Study 35351147 — intervention group
Group type: EXPERIMENTAL
Intervention: We Care Solar Suitcase intervention (solar electric system providing lighting and power)
Number of subjects: 85
Study 35351147 — intervention group
Group type: EXPERIMENTAL
Intervention: We Care Solar Suitcase intervention
Number of subjects: 85
Study 33998206 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of TXA (15 mg/kg) 30 minutes before operation (Group A)
Number of subjects: 107
Study 33998206 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical administration of TXA (1 g injected into the medullary cavity after proximal femur grooving) (Group B)
Number of subjects: 107
Study 33998206 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of TXA (Groups A and B methods) (Group C)
Number of subjects: 107
Study 33998206 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but can be inferred as no TXA administration)
Number of subjects: 107
Study 34560833 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm-water footbath
Number of subjects: 68
Study 34560833 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 68
Study 35570728 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote supervised group (RSG)
Number of subjects: 66
Study 35570728 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised group (UG)
Number of subjects: 66
Study 35570728 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 66
Study 34021585 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimegepant
Number of subjects: 257
Study 32891212 — intervention group
Group type: EXPERIMENTAL
Intervention: Vosoritide 15.0 μg/kg
Number of subjects: 121
Study 32891212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 33484513 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh fixation (Group A)
Number of subjects: 98
Study 33484513 — intervention group
Group type: COMPARATOR
Intervention: Non-mesh fixation (Group B)
Number of subjects: 98
Study 33484513 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 98
Study 32493199 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive ventilation (NIV)
Number of subjects: 0
Study 32493199 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal cannulae
Number of subjects: 0
Study 32493199 — intervention group
Group type: COMPARATOR
Intervention: Conventional invasive ventilation
Number of subjects: 0
Study 35500205 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-written instructions
Number of subjects: 82
Study 35500205 — intervention group
Group type: COMPARATOR
Intervention: Written-only instructions
Number of subjects: 82
Study 35500205 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study 34298539 — intervention group
Group type: EXPERIMENTAL
Intervention: SDL-Seg algorithm
Number of subjects: 29
Study 34298539 — intervention group
Group type: COMPARATOR
Intervention: basic U-Net
Number of subjects: 29
Study 32293478 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipyretic
Number of subjects: 0
Study 32293478 — intervention group
Group type: EXPERIMENTAL
Intervention: Abortive (corticosteroids)
Number of subjects: 0
Study 32293478 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis (colchicine or cimetidine)
Number of subjects: 0
Study 32293478 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical (tonsillectomy)
Number of subjects: 0
Study 34844978 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant plus Everolimus
Number of subjects: 37
Study 34844978 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant, Everolimus, and Anastrozole
Number of subjects: 37
Study 34844978 — intervention group
Group type: COMPARATOR
Intervention: Fulvestrant alone
Number of subjects: 37
Study 34844978 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline CTC and ctDNA
Number of subjects: 37
Study 33974019 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital intervention (18-session, low-intensity, delivered over 6 weeks via smartphone)
Number of subjects: 1312
Study 33974019 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1312
Study 33338989 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate stress
Number of subjects: 62
Study 33338989 — intervention group
Group type: COMPARATOR
Intervention: Low/no stress, mental stress, physical stress
Number of subjects: 62
Study 35554859 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening binge alcohol consumption (1 g/kg in men, 0.85 g/kg in women)
Number of subjects: 30
Study 35554859 — intervention group
Group type: COMPARATOR
Intervention: Fluid control
Number of subjects: 30
Study 35554859 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening binge alcohol consumption
Number of subjects: 30
Study 34039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Spectral endoscopy
Number of subjects: 20
Study 34039635 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning algorithm for spectral classification
Number of subjects: 20
Study 34039635 — intervention group
Group type: COMPARATOR
Intervention: Application-specific color filters
Number of subjects: 20
Study 35272319 — intervention group
Group type: EXPERIMENTAL
Intervention: Urgent PC
Number of subjects: 501
Study 35272319 — intervention group
Group type: COMPARATOR
Intervention: Generic posterior tibial neurostimulator
Number of subjects: 501
Study 36316078 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex multidisciplinary intervention to improve initial medication adherence (IMA)
Number of subjects: 0
Study 36316078 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35049214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review (intervention group)
Number of subjects: 100
Study 35049214 — intervention group
Group type: COMPARATOR
Intervention: Control group (without medication reconciliation)
Number of subjects: 100
Study 33150399 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported daytime napping
Number of subjects: 0
Study 33150399 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-measured 'eveningness' and sleep duration, self-reported daytime sleepiness
Number of subjects: 0
Study 33892330 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital penetration only
Number of subjects: 109
Study 33892330 — intervention group
Group type: COMPARATOR
Intervention: Penile vaginal penetration only
Number of subjects: 109
Study 36397173 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized perioperative blood pressure management
Number of subjects: 1272
Study 36397173 — intervention group
Group type: COMPARATOR
Intervention: Routine blood pressure management
Number of subjects: 1272
Study 32034490 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time colonoscopy and annual fecal immunochemical test (FIT)
Number of subjects: 9751
Study 32034490 — intervention group
Group type: COMPARATOR
Intervention: Annual fecal immunochemical test (FIT)
Number of subjects: 9751
Study 32034490 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time colonoscopy and annual FIT
Number of subjects: 9751
Study 32034490 — intervention group
Group type: COMPARATOR
Intervention: Annual FIT
Number of subjects: 9751
Study 35704124 — intervention group
Group type: EXPERIMENTAL
Intervention: Text reminders generated by real-time enabled electronic monitors and data-informed counseling through 3 months postpartum (PPM3)
Number of subjects: 133
Study 35704124 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 133
Study 35704124 — intervention group
Group type: EXPERIMENTAL
Intervention: Text reminders and counseling
Number of subjects: 133
Study 32757437 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable cardioverter-defibrillator (WCD)
Number of subjects: 0
Study 32757437 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34040607 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-HIV clade B vaccine (MVA-B)
Number of subjects: 0
Study 32927677 — intervention group
Group type: EXPERIMENTAL
Intervention: Black soybean cookie (40 g daily, containing 20 g roasted black soybean powder)
Number of subjects: 22
Study 35358820 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-Solving Skills Training (PSST)
Number of subjects: 50
Study 35358820 — intervention group
Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 50
Study 33190843 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 23
Study 33190843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 32304981 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular or intranasal administration of naloxone
Number of subjects: 46
Study 35653174 — intervention group
Group type: EXPERIMENTAL
Intervention: Student Bodies‐AN (SB‐AN) - intervention group (IG)
Number of subjects: 168
Study 35653174 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (CG)
Number of subjects: 168
Study 32202124 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling combined with manual therapy (DN+MT)
Number of subjects: 101
Study 32202124 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling combined with manual therapy (SDN+MT)
Number of subjects: 101
Study 34825704 — intervention group
Group type: COMPARATOR
Intervention: Active agent
Number of subjects: 0
Study 34825704 — intervention group
Group type: COMPARATOR
Intervention: Censored, time-lagged categorical outcome
Number of subjects: 0
Study 34192327 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fiber posts with direct composite
Number of subjects: 141
Study 34192327 — intervention group
Group type: COMPARATOR
Intervention: Cast metal posts without crowns
Number of subjects: 141
Study 34192327 — intervention group
Group type: COMPARATOR
Intervention: Glass fiber posts with crowns
Number of subjects: 141
Study 34192327 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite restorations
Number of subjects: 141
Study 32951600 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural residence
Number of subjects: 1730
Study 32951600 — intervention group
Group type: COMPARATOR
Intervention: Non-rural residence
Number of subjects: 1730
Study 35500352 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone administration
Number of subjects: 0
Study 35500352 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 0
Study 34720494 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.0055%)
Number of subjects: 49
Study 34720494 — intervention group
Group type: COMPARATOR
Intervention: Balanced Salt Solution (BSS)
Number of subjects: 49
Study 33032123 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency Manual (EM) available during simulation
Number of subjects: 304
Study 36175092 — intervention group
Group type: EXPERIMENTAL
Intervention: Film-forming skin protecting leave-on products
Number of subjects: 210
Study 36175092 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipophilic skin protecting leave-on products
Number of subjects: 210
Study 36175092 — intervention group
Group type: COMPARATOR
Intervention: Standard incontinence care alone
Number of subjects: 210
Study 33522926 — intervention group
Group type: EXPERIMENTAL
Intervention: Training for ANC providers on person-centred communication (PCC) for FGM prevention
Number of subjects: 60
Study 33522926 — intervention group
Group type: COMPARATOR
Intervention: Provision of FGM-related clinical guidelines and handbook, anti-FGM policies and posters
Number of subjects: 60
Study 33004705 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% H2 inhalation during exercise
Number of subjects: 16
Study 33004705 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% H2 inhalation during resting state
Number of subjects: 16
Study 33004705 — intervention group
Group type: COMPARATOR
Intervention: Control gas during exercise
Number of subjects: 16
Study 33004705 — intervention group
Group type: COMPARATOR
Intervention: Control gas during resting state
Number of subjects: 16
Study 34529156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid (NC) therapy + hyaluronic acid (HA) administered twice a day via nasal douche device (Group 3)
Number of subjects: 76
Study 34529156 — intervention group
Group type: COMPARATOR
Intervention: Nasal corticosteroid (NC) therapy + normal saline solution (NSS) administered twice a day (Group 2)
Number of subjects: 76
Study 34529156 — intervention group
Group type: COMPARATOR
Intervention: Nasal corticosteroid (NC) therapy only (Group 1)
Number of subjects: 76
Study 34529156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal corticosteroid (NC) therapy + hyaluronic acid (HA) (Group 3)
Number of subjects: 76
Study 32366308 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Clinical Pharmacy Service (VCPS) via telehealth
Number of subjects: 2080
Study 36217922 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based nutrition program (phase 1 only)
Number of subjects: 311
Study 36217922 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based nutrition program (both phases)
Number of subjects: 311
Study 34694998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseD
Number of subjects: 12
Study 34694998 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseL
Number of subjects: 12
Study 34694998 — intervention group
Group type: COMPARATOR
Intervention: Cerebellar transcranial direct current stimulation (ctDCS) PhaseD and PhaseL
Number of subjects: 12
Study 32393980 — intervention group
Group type: EXPERIMENTAL
Intervention: High-saturated-fat meal
Number of subjects: 51
Study 35728220 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma intervention (12-month respiratory nurse-led asthma assessment and a class-based asthma education programme for four months)
Number of subjects: 675
Study 35728220 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (class-based science education programme for four months)
Number of subjects: 675
Study 35728220 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma intervention
Number of subjects: 675
Study 35728220 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 675
Study 34767149 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of rectal diclofenac 100 mg and epinephrine spray (0.02%) on duodenal papilla (group A)
Number of subjects: 882
Study 34767149 — intervention group
Group type: COMPARATOR
Intervention: Combination of rectal diclofenac 100 mg and saline spray on duodenal papilla (group B)
Number of subjects: 882
Study 36442318 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification program (LMP)
Number of subjects: 94
Study 36442318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 94
Study 36442318 — intervention group
Group type: COMPARATOR
Intervention: Placebo (written suggestions for lifestyle changes)
Number of subjects: 94
Study 33416951 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]FDG PET/CT radiomics signature
Number of subjects: 80
Study 33416951 — intervention group
Group type: EXPERIMENTAL
Intervention: [18F]FDG PET/CT radiomics nomogram (D-PET/CT model)
Number of subjects: 80
Study 32446864 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced frequency BCG instillations (9 total instillations)
Number of subjects: 345
Study 32446864 — intervention group
Group type: COMPARATOR
Intervention: Standard BCG instillations (15 total instillations)
Number of subjects: 345
Study 34379922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabotegravir (CAB-LA) 600 mg intramuscularly every 8 weeks
Number of subjects: 4566
Study 34379922 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) daily
Number of subjects: 4566
Study 33218893 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 0
Study 33218893 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 0
Study 32632661 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered stents
Number of subjects: 0
Study 32632661 — intervention group
Group type: COMPARATOR
Intervention: Uncovered stents
Number of subjects: 0
Study 36375487 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebamipide
Number of subjects: 33